NCT05718817Phase 3Enrolling by invitation

An Open-label Study of XEN1101 in Epilepsy

Study sponsor: Xenon Pharmaceuticals Inc. · XENE

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2033-04Estimated

Enrollment · participants880Estimated

Source updated2026-09-11Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-04-13 · 1 field changed

Primary completion date changed

− Before

~~Jul 2028~~

+ After

Apr 2033

Check registry source